Grégoire Cullot

Grégoire has received his Ph.D. in Cell Biology and Physiopathology from the University of Bordeaux (France) in December 2019 in the lab of Prof. Moreau-Gaudry. His work was interested in the gene therapy of congenital erythropoietic porphyria with a focus on the genotoxicity of CRISPR-Cas9 system. He continued with a one-year post-doctoral experience to apply the SHERLOCK detection system in the context of chronic myeloid leukemia. Grégoire joined the Corn lab as a post-doctoral researcher in January 2021. His research interests include gene editing and monogenic diseases, with a special focus on gene therapy of sickle cell disease.